Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives?
Sheridan
D J
DJ
Academic Cardiology Unit, National Heart and Lung Institute, Imperial College of Science Technology and Medicine, St Mary's Hospital, London, UK.
Kingsbury
M P
MP
Flores
N A
NA
D000959:Antihypertensive Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male
D000959:Antihypertensive Agents